Author | Ian Flinn, MD, PhD | OncLive

Author | Ian Flinn, MD, PhD

Articles

Dr. Flinn on the Utility of Tafasitamab in Relapsed/Refractory DLBCL

June 12, 2020

Video

Ian W. Flinn, MD, PhD, discusses the utility of tafasitamab (MOR208) in patients with relapsed diffuse large B-cell lymphoma (DLBCL).

Dr. Flinn on the iNNOVATE Trial in Waldenstrom Macroglobulinemia

August 08, 2018

Video

Ian Flinn, MD, PhD, director of the Blood Cancer Research Program, Sarah Cannon Research Institute, discusses the iNNOVATE trial in Waldenstrom macroglobulinemia.

Dr. Flinn on the RELEVANCE Trial in Follicular Lymphoma

July 17, 2018

Video

Ian Flinn, MD, PhD, director of the Blood Cancer Research Program, Sarah Cannon Research Institute, discusses the RELEVANCE trial in follicular lymphoma.

x